Flexion therapeutics, inc. (FLXN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13
Cash flows from operating activities
Net loss

-145,037

-149,773

-156,832

-162,240

-169,628

-169,659

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-78,958

-

-62,350

-55,705

-53,956

-46,315

-40,552

-36,450

-29,945

-27,313

-23,198

-21,263

-19,930

-18,186

0

0

0

Adjustments to reconcile net loss to cash used in operating activities
Depreciation

1,100

1,100

900

1,000

1,337

1,700

2,044

2,173

2,110

2,000

1,907

1,809

1,418

1,151

808

425

384

238

165

149

132

120

110

101

96

79

0

0

0

Amortization of right-of-use assets

1,475

1,337

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock-based compensation expense

16,699

15,901

15,914

15,888

15,655

15,459

15,612

14,442

12,821

11,542

9,377

8,251

7,507

6,770

6,447

5,865

5,216

4,583

3,797

3,334

3,022

2,450

1,975

1,994

1,400

996

0

0

0

Non cash interest expense

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash charges

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

37

40

35

20

24

16

0

0

0

-

-

-

-

Accretion of discount on marketable securities

965

1,337

1,672

1,695

1,521

1,320

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of (discount) premium on marketable securities

-

-

-

-

-

-

-

-

-

-

-

0

688

-

778

781

958

871

776

701

465

366

233

118

74

151

0

0

0

Loss on disposal of fixed assets

0

-

-

-

-

-

-

-

-

-

-

-

-

-2,283

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and debt issuance costs

8,907

8,714

8,524

8,178

7,990

7,805

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Premium paid on securities purchased

-

-

-

-

-

214

396

281

596

857

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-cash charges

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

Changes in operating assets and liabilities:
Accounts receivable

15,232

23,994

20,518

17,529

12,733

12,711

0

0

0

-

-

-

-

-95

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

Inventory

8,449

7,674

8,351

8,251

6,844

5,244

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,159

-126

559

1,239

633

2,097

1,067

640

-284

-387

1,995

1,064

2,818

2,873

980

161

111

526

212

536

644

320

418

450

407

-343

0

0

0

Accounts payable

-985

1,702

2,265

5,499

7,599

5,141

4,468

2,823

1,244

4,188

2,056

-669

154

-993

163

2,189

-21

1,581

610

321

439

518

431

738

1,382

475

0

0

0

Accrued expenses and other current liabilities

4,686

5,326

6,914

3,777

5,516

707

6,134

5,353

6,157

9,432

9,200

5,079

2,846

2,766

333

-1,268

1,656

429

1,131

2,739

271

1,017

480

-834

-320

-124

0

0

0

Lease liabilities

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-138,974

-148,758

-152,474

-156,756

-153,419

-160,419

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-69,870

-

-52,470

-45,228

-42,967

-38,949

-34,294

-29,920

-26,636

-23,144

-20,344

-19,541

-17,643

-16,186

0

0

0

Cash flows from investing activities
Purchases of property and equipment

6,070

3,894

1,282

1,359

1,586

852

952

1,025

1,462

2,146

2,157

2,444

6,364

8,440

10,947

11,448

7,758

5,197

2,890

2,167

1,290

802

346

168

444

405

0

0

0

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-48

0

0

0

-

-

-

-

98

0

0

0

Purchases of marketable securities

-

115,466

171,471

253,465

266,244

222,482

314,114

303,649

363,879

356,754

315,683

303,577

218,476

196,061

119,467

57,125

59,379

145,798

113,489

116,677

126,077

79,383

72,362

66,568

50,017

15,015

0

0

0

Sale and redemption of marketable securities

156,759

234,124

270,560

290,907

368,019

348,918

306,067

300,937

279,362

240,228

234,828

185,513

116,378

72,147

82,895

111,166

126,334

137,702

106,279

76,908

57,950

30,735

27,435

19,285

27,160

31,160

0

0

0

Net cash provided by investing activities

111,531

114,764

97,807

36,083

100,189

125,584

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows from financing activities
Proceeds from revolving line of credit

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-108,862

-

-47,495

42,617

59,221

-13,245

-10,076

-41,913

-69,393

-49,451

-45,273

-47,451

-23,301

15,641

0

0

0

Payment of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

42

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the offering of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

162,137

0

0

0

-

-

-

-

Payments on notes payable

-

14,367

16,867

10,000

10,000

10,000

10,000

10,000

10,000

8,333

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

Proceeds from borrowings under term loan

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

0

0

0

Payments of public offering costs

-

-

-

-

-

-

-

-

-

490

0

0

0

-

-

-

-

225

459

459

645

1,517

0

0

0

-

-

-

-

Proceeds from the exercise of stock options

0

-

-

-

-

1,653

2,677

4,178

3,713

3,858

0

0

0

-

-

-

-

593

237

279

148

304

0

0

0

-

-

-

-

Net cash provided by (used in) financing activities

51,527

29,018

24,670

-8,191

-6,739

-6,325

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase in cash and cash equivalents

24,084

-4,976

-29,997

-128,864

-59,969

-41,160

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

1,529

-

1,025

757

517

572

447

458

556

364

388

402

405

367

0

0

0

Non-cash investing and financing activities
Right-of-use asset obtained in exchange for operating lease obligation

-

9,560

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Public offering costs included in accounts payable or accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Purchases of property and equipment in accounts payable and accrued expenses

0

-

-

-

-

986

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

-

-

-

-

-

-

-

-

-

-

-

-

162,870

-

93,267

93,281

15,686

12,040

103,512

88,158

87,202

159,505

66,511

66,912

67,513

3,898

0

0

0

Net increase in cash, cash equivalents, and restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-15,862

-

-6,698

90,670

31,940

-40,154

59,141

16,324

-8,826

86,909

893

-80

26,567

3,352

0

0

0

Supplemental disclosures of cash flow information
Cash paid for interest

8,582

8,049

7,597

7,558

7,718

7,874

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of convertible preferred stock into common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

74,806

0

0

0

-

-

-

-

Purchases of property and equipment in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-